Market Cap | ₹33,641Cr |
ROE | 28.72% |
P/E Ratio(TTM) | 100.61 |
EPS(TTM) | 8.74 |
P/B Ratio | 19.68 |
Dividend Yield | 0.00% |
Industry P/E | 34.34 |
Book Value | 44.68 |
Debt to Equity | 0.16 |
Face Value | 1 |
Parent Organisation | Cohance Lifesciences |
Managing Director | Dr. Vetukuri Venkata Prasada Raju |
NSE Symbol | COHANCE |
FUND NAME | AUM(%) |
---|---|
DSP Healthcare Fund Direct Growth | 7.79% |
UTI Healthcare Fund Direct Growth | 2.53% |
DSP Focused Direct Plan Growth | 2.27% |
Invesco India Focused Fund Direct Growth | 2.23% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.39 | ||
Emcure Pharmaceuticals | NA (0.00%) | 35.44 | ||
Wockhardt | NA (0.00%) | -188.59 | ||
Concord Biotech | NA (0.00%) | 49.39 |